liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Structuring the pharmaceutical parent company organization: A value-based approach, The Case of TPICO
Linköping University, Department of Management and Engineering. Linköping University, The Institute of Technology. (internationalization, MBA ProMA)
Linköping University, Department of Management and Engineering, Industrial Marketing and Industrial Economics. Linköping University, The Institute of Technology. (internationalization)
Linköping University, Department of Management and Engineering, Industrial Marketing and Industrial Economics. Linköping University, The Institute of Technology. (Internationalization)
2010 (English)In: IASK International Conference Global Management, International Association for the Scientific Knowledge, 2010, 471-476 p.Conference paper, Published paper (Other academic)
Abstract [en]

Today’s, the parent company has the great role in managing and monitoring subsidiaries and companies and promoting their industrial activities. But, the main problem for pharmaceutical parent companies is the lack of clarity and confusion of   responsibilities between units .The successful parenting needs to create the element of 'fit' between the ways parent operates – parent characteristics and   its business characteristics. However, the main parent characteristic is parent structure and restructuring is the main challenge in changing and unstable pharmaceutical market. In fact, the parent strategy should determine how value can be added to every organizational structure and parent structure should be proportionate to its dominant value creation strategy. The value drivers are very different in pharmaceutical industry regarding fast changing technology. The aim of this study is to explore an appropriate value-creating structure for the largest pharmaceutical parent company in Iran, TPICO. This study concentrates the sources of value in this special domain and restructuring the parent company by considering the dominant value-creating strategy and pharmaceutical value drivers.

Place, publisher, year, edition, pages
International Association for the Scientific Knowledge, 2010. 471-476 p.
Keyword [en]
Corporate strategy, Parent company structure, Pharmaceutical parent company structure, Value creation
National Category
Business Administration
Identifiers
URN: urn:nbn:se:liu:diva-73484ISBN: 9789898295019 (print)OAI: oai:DiVA.org:liu-73484DiVA: diva2:473029
Conference
IASK Global Management, 8-10 Nvember 2010, Oviedo, Spain
Projects
MBA ProMA
Available from: 2012-01-04 Created: 2012-01-04 Last updated: 2014-02-27Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Saeedi, Mohammad RezaDadfar, Hossein

Search in DiVA

By author/editor
Saeedi, Mohammad RezaDadfar, Hossein
By organisation
Department of Management and EngineeringThe Institute of TechnologyIndustrial Marketing and Industrial Economics
Business Administration

Search outside of DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 123 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf